Overexpression of the oxygen sensors PHD-1, PHD-2, PHD-3, and FIH Is associated with tumor aggressiveness in pancreatic endocrine tumors. by Couvelard, A, Deschamps, L, Rebours, V, Sauvanet, A, Gatter, K, Pezzella, F, Ruszniewski, P, Bedossa, P

Identification of potential therapeutic targets by gene-expression profiling in pancreatic endocrine tumors. by Couvelard, A, Hu, J, Steers, G, O'Toole, D, Sauvanet, A, Belghiti, J, Bedossa, P, Gatter, K, Ruszniewski, P, Pezzella, F

Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progressio... by Couvelard, A, O'Toole, D, Turley, H, Leek, R, Sauvanet, A, Degott, C, Ruszniewski, P, Belghiti, J, Harris, A, Gatter, K, Pezzella, F

Expression of hypoxia-inducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic ductal adenocarcinomas. by Couvelard, A, O'Toole, D, Leek, R, Turley, H, Sauvanet, A, Degott, C, Ruszniewski, P, Belghiti, J, Harris, A, Gatter, K, Pezzella, F

Gastroenteropancreatic neuroendocrine tumours. by Modlin, I, Oberg, K, Chung, D, Jensen, RT, de Herder, W, Thakker, R, Caplin, M, Delle Fave, G, Kaltsas, G, Krenning, E, Moss, S, Nilsson, O, Rindi, G, Salazar, R, Ruszniewski, P, Sundin, A

Rapid and sustained relief from the symptoms of carcinoid syndrome: results from an open 6-month study of the 28-day prolonged-release formulation of lanreotide. by Ruszniewski, P, Ish-Shalom, S, Wymenga, M, O'Toole, D, Arnold, R, Tomassetti, P, Bax, N, Caplin, M, Eriksson, B, Glaser, B, Ducreux, M, Lombard-Bohas, C, de Herder, W, Delle Fave, G, Reed, N, Seitz, J, Van Cutsem, E, Grossman, A, Rougier, P, Schmidt, W, Wiedenmann, B